News - Diabetes, alogliptin

Filter

Current filters:

Diabetesalogliptin

Popular Filters

EMA accepts Takeda's submission of diabetes drug alogliptin

24-05-2012

Japan's largest drugmaker, Takeda Pharmaceuticals (TYO: 4502), says its European subsidiary has received…

alogliptinDiabetesEuropeFuriex PharmaceuticalsPharmaceuticalRegulationTakeda Pharmaceuticals

US FDA again delays action on Takeda's alogliptin diabetes drug

26-04-2012

Japan's largest drugmaker Takeda Pharmaceutical (TYO: 4502) says it has received a complete response…

ActosalogliptinDiabetesNorth AmericaPharmaceuticalRegulationTakeda Pharmaceuticals

US FDA sets PUDFA date for Takeda diabetes drug alogliptin and fixed-dose alogliptin/pioglitazone

02-11-2011

The US subsidiary of Japan’s largest drugmaker Takeda Pharmaceutical (TYO: 4502) said yesterday…

alogliptinDiabetesNorth AmericaPharmaceuticalPioglitazoneRegulationTakeda Pharmaceuticals

Back to top